MTOR and glioblastoma: A recent study involved developing a brain-targeted liposome and disulfiram/copper synergistic delivery system (CDX-LIPO) to remodel tumor metabolism and tumor immune microenvironment(TIME) by modulating the mTOR pathway, and honokiol can interact with disulfiram/copper to produce a synergistic effect for the combined treatment of GBM (87).